首页> 外国专利> APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIA

APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIA

机译:Myricetin化合物在新型冠状病毒肺炎预防和治疗中的应用

摘要

Application of a myricetin compound in the preparation of drugs for prevention and treatment of novel coronavirus pneumonia. Specifically, the present invention relates to use of a myricetin compound and a pharmaceutical composition as a 2019 novel coronavirus (SARS-CoV-2) 3CL protease inhibitor in the preparation of drugs for treatment and/or prevention and alleviation of related diseases such as respiratory tract infections and pneumonia caused by 2019 novel coronavirus infections.
机译:一种霉味素化合物在新型冠状病毒肺炎预防治疗中的制备中的应用。 具体地,本发明涉及Myricetin化合物和药物组合物作为2019年新型冠状病毒(SARS-COV-2)3CL蛋白酶抑制剂,用于制备用于治疗和/或预防和缓解相关疾病(如呼吸道)的药物 由2019年新型冠状病毒感染引起的道路感染和肺炎。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号